Open AccessSurgical treatment to increase the success rate of multidrug-resistant tuberculosis
Author(s) -
Milena Adina Man,
David P. Nicolau
Publication year - 2012
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezs215
Subject(s) - medicine , tuberculosis , surgery , rifampicin , multi drug resistant tuberculosis , drug resistance , population , mycobacterium tuberculosis , environmental health , pathology , microbiology and biotechnology , biology
Mycobacterium tuberculosis infects more than one-third of the world's population and causes an estimated 2-3 million deaths annually. The medical treatment of multidrug-resistant tuberculosis (MDR-TB) can cure 50-75% of cases. The median prevalence of new MDR-TB cases is 1.1%, while that of previously treated cases is 7%.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom